Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia

Oncotarget (2016) - Comments
pubmed: 27821800 doi: 10.18632/oncotarget.13035 issn: 1949-2553

Carolina Simioni, Simona Ultimo, Alberto M. Martelli, Giorgio Zauli, Daniela Milani, James A. McCubrey, Silvano Capitani, Luca M. Neri